2023 CADTH Symposium — Official Opening
Opening remarks at the 2023 CADTH Symposium from Suzanne McGurn, President and Chief Executive Officer of CADTH, and speaker Dr. Stephen Lucas, Deputy Minister, Health Canada.
Видео 2023 CADTH Symposium — Official Opening канала Canada’s Drug Agency
Видео 2023 CADTH Symposium — Official Opening канала Canada’s Drug Agency
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
There's Always Evidence (Part 2) - Beyond RCTs: The Many Benefits of Observational Studies
CADTH in Conversation with…. Professor Gillian Leng CBE, Chief Executive of NICE
INFORMATION SESSION — Introducing CADTH’s New Post-Market Drug Evaluation Program
2017 CADTH Symposium: Janet Knox
2017 CADTH Symposium: Robyn Lim
CADTH Drug Reimbursement Reviews
How CADTH Expert Committees Deliberate
2017 CADTH Symposium: Ken Milne
Release of the CADTH Health Economic Guidelines
Recommendation Mapping: A New Approach to Digitizing and Presenting Living Guidelines
There's Always Evidence Part 3 - Observational Studies: A Deeper Dive
Dr. Wendy Ungar, Recipient of the 2020 Dr. Jill M. Sanders Award of Excellence in HTA
Impact of Zika Virus-Associated Neurological Disorders on Health-Related Quality of Life
2018 CADTH Symposium — Oral Presentations: Opioids
2018 CADTH Symposium: Dr. Tony Fields, the 2018 Dr. Jill M. Sanders Award Recipient
Implementing Health Technology–Related Decisions
Toward Standardized Structured Reporting for the Management of Multiple Myeloma in Alberta
There’s Always Evidence: Part 1
COVID-19 and the Surge in Virtual Care: Lessons Learned and Challenges to Come
Non-Pharmacological Interventions for Chronic Non-Cancer Pain: Acupuncture
Community-Based Aerosol Transmission Of COVID-19 and HVAC Systems